Patents by Inventor Kenneth Moya

Kenneth Moya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10342851
    Abstract: The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: July 9, 2019
    Assignees: Centre National de la Recherche Scientifique, College de France
    Inventors: Alain Prochiantz, Kenneth Moya, Rajiv Joshi
  • Publication number: 20180271937
    Abstract: The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons.
    Type: Application
    Filed: March 16, 2018
    Publication date: September 27, 2018
    Applicants: Centre National de la Recherche Scientifique, College de France
    Inventors: Alain Prochiantz, Kenneth Moya, Rajiv Joshi
  • Patent number: 9950033
    Abstract: The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: April 24, 2018
    Assignees: Centre National de la Recherche Scientifique, College de France
    Inventors: Alain Prochiantz, Kenneth Moya, Rajiv Joshi
  • Publication number: 20150057231
    Abstract: The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons
    Type: Application
    Filed: February 29, 2012
    Publication date: February 26, 2015
    Applicants: COLLEGE DE FRANCE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Alain Prochiantz, Kenneth Moya, Rajiv Joshi